Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABOS Acumen Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.19 -3.3%	$15.00 ➝ $11.00	Buy ➝ Buy
ABOS Acumen Pharmaceuticals	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Colin Bristow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.19 -3.3%	$6.00 ➝ $4.00	Buy ➝ Buy
ABUS Arbutus Biopharma	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keay Nakae Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.50 +7.0%	$5.00 ➝ $5.00	Buy ➝ Buy
AGX Argan	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Brown Subscribe to MarketBeat All Access for the recommendation accuracy rating	$138.81 +20.5%	$150.00	Hold ➝ Buy
AIR AAR	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Ciarmoli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.14 -16.4%	$81.00 ➝ $78.00	Buy ➝ Buy
AMAT Applied Materials	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$145.06 -1.8%	$195.00	Hold ➝ Buy
APEI American Public Education	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.48 -2.8%	$28.00	Buy
APP AppLovin	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$272.38 +4.1%	$385.00	Outperform
APP AppLovin	Reiterated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Sanderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$272.38 +4.1%		Buy ➝ Buy
ARM ARM	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lee Simpson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$107.80 -4.2%	$175.00 ➝ $150.00	Overweight ➝ Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ATRC AtriCure	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Plovanic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.83 -7.4%	$66.00 ➝ $52.00	Buy ➝ Buy
AXS AXIS Capital	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the recommendation accuracy rating	$99.57 -0.1%	$118.00 ➝ $120.00	Outperform ➝ Outperform
AYI Acuity Brands	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph O'Dea Subscribe to MarketBeat All Access for the recommendation accuracy rating	$262.44 -2.0%	$336.00 ➝ $290.00	Equal Weight ➝ Equal Weight
BABA Alibaba Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$132.49 -2.3%	$140.00 ➝ $170.00	Outperform ➝ Outperform
BEAM Beam Therapeutics	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alec Stranahan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.21 +0.1%	$42.00 ➝ $42.00	Neutral ➝ Buy
BLCO Bausch + Lomb	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.18 -5.5%	$24.00 ➝ $15.00	Overweight ➝ Equal Weight
BODI Beachbody	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.51 -6.2%	$13.00 ➝ $13.00	Buy ➝ Buy
BROS Dutch Bros	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Agnes Lim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.49 -3.9%	$89.00 ➝ $89.00	Buy ➝ Buy
BRZE Braze	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$50.00 ➝ $50.00	Buy ➝ Buy
BRZE Braze	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$45.00 ➝ $50.00	Buy ➝ Buy
BRZE Braze	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$48.00 ➝ $50.00	Buy ➝ Buy
BRZE Braze	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$50.00 ➝ $55.00	Overweight ➝ Overweight
BRZE Braze	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$45.00 ➝ $48.00	Outperform ➝ Outperform
BRZE Braze	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.51 +2.2%	$50.00 ➝ $55.00	Buy ➝ Buy
CAMT Camtek	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.00 -6.3%	$120.00 ➝ $85.00	Buy ➝ Buy
CART Maplebear	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.73 -1.9%	$44.00	Sector Perform
CHKP Check Point Software Technologies	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$228.37 -1.3%	$245.00 ➝ $275.00	Market Perform ➝ Outperform
CHRW C.H. Robinson Worldwide	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$101.13 -0.5%	$122.00 ➝ $119.00	Buy ➝ Buy
CLSD Clearside Biomedical	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 -7.8%	$6.00 ➝ $4.00	Buy ➝ Buy
CLSD Clearside Biomedical	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 -7.8%	$6.00 ➝ $6.00	Buy ➝ Buy
CMA Comerica	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.73 -1.5%	$70.00 ➝ $67.00	Equal Weight ➝ Equal Weight
CMPS COMPASS Pathways	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Duncan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.94 -4.9%		Overweight ➝ Overweight
CODX Co-Diagnostics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.32 -18.3%	$1.50 ➝ $1.00	Neutral ➝ Neutral
CPT Camden Property Trust	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Joseph Subscribe to MarketBeat All Access for the recommendation accuracy rating	$122.17 +0.2%	$125.00 ➝ $138.00	Neutral ➝ Buy
CRGY Crescent Energy	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Freeman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.13 -1.3%	$23.00 ➝ $18.00	Strong-Buy ➝ Strong-Buy
CSTL Castle Biosciences	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.94 -0.8%	$30.00	Buy ➝ Buy
DASH DoorDash	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$182.61 -5.9%	$230.00	Outperform
DDD 3D Systems	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Troy Jensen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.12 -1.6%	$5.75 ➝ $5.00	Overweight ➝ Overweight
DDD 3D Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.12 -1.6%		Hold ➝ Hold
DFIN Donnelley Financial Solutions	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.83 -2.8%	$72.00 ➝ $72.00	Buy ➝ Buy
The unusual signal flashing green again (Ad) Something fascinating happened in April... While a lot of Wall Street institutions were opening new positions in a falling stock, something different showed up on my screen. A special set of candles had just turned green - signaling the kind of momentum surge I'd seen only a handful of times before. What happened next? The stock soared 45% on the underlying stock in just a few weeks and 227% for anyone who traded the options. Naturally, there would have been smaller wins and those that would not have worked out, but this wasn't some penny stock or crypto play… It was ARM Holdings - a major semiconductor player that had just shed 9% of its value. I’ve put together everything you need to know here.
DLR Digital Realty Trust	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Omotayo Okusanya Subscribe to MarketBeat All Access for the recommendation accuracy rating	$142.10 -2.0%	$211.00 ➝ $177.00	Outperform ➝ Outperform
DLTR Dollar Tree	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.75 -5.5%	$100.00 ➝ $95.00	Buy ➝ Buy
DOOO BRP	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Hardiman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.00 -4.1%	$29.00 ➝ $27.00	Sell ➝ Sell
DSGX The Descartes Systems Group	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Treiber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.24 -1.4%	$130.00 ➝ $130.00	Outperform ➝ Outperform
DTIL Precision BioSciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Trucchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.70 +3.5%	$60.00 ➝ $60.00	Buy ➝ Buy
DV DoubleVerify	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.33 -4.8%	$20.00 ➝ $14.00	Outperform ➝ Neutral
DV DoubleVerify	Downgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Kesavabhotla Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.33 -4.8%		Strong-Buy ➝ Hold
EDAP Edap Tms	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.15 -3.2%	$5.00 ➝ $4.50	Overweight ➝ Overweight
EDAP Edap Tms	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.15 -3.2%	$19.00 ➝ $19.00	Buy ➝ Buy
EE Excelerate Energy	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.99 -6.3%		Underweight ➝ Underweight
ELV Elevance Health	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$431.84 0.0%		Outperform ➝ Outperform
EQ Equillium	Downgraded by	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.41 -16.9%		Strong-Buy ➝ Hold
EQ Equillium	Reiterated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.41 -16.9%	$3.00 ➝ $1.00	Outperform ➝ Market Perform
EQIX Equinix	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$803.00 -2.7%	$1,094.00 ➝ $1,053.00	Outperform ➝ Outperform
ETWO E2open Parent	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Hotchkiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.14 -5.5%	$2.60 ➝ $2.30	Sell ➝ Sell
EXAS Exact Sciences	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.66 -3.0%	$60.00	Buy ➝ Buy
FEMY Femasys	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Emily Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.29 -3.4%	$15.00 ➝ $15.00	Buy ➝ Buy
FITB Fifth Third Bancorp	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.81 -2.4%	$54.00 ➝ $50.00	Overweight ➝ Overweight
FRT Federal Realty Investment Trust	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Bilerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$96.80 +0.0%	$135.00 ➝ $106.00	Buy ➝ Neutral
FUL H.B. Fuller	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.76 -5.0%	$60.00 ➝ $50.00	Underweight ➝ Underweight
GANX Gain Therapeutics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keay Nakae Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.89 -8.7%	$6.00 ➝ $6.00	Buy ➝ Buy
GEVO Gevo	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.14 -9.9%	$14.00 ➝ $14.00	Buy ➝ Buy
GOVX GeoVax Labs	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.11 -12.6%	$18.00 ➝ $18.00	Buy ➝ Buy
GS The Goldman Sachs Group	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$543.04 -2.8%	$720.00 ➝ $680.00	Overweight ➝ Overweight
GTY Getty Realty	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Goldsmith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.64 +0.2%	$32.00	Neutral
HOOD Robinhood Markets	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Todaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.92 -4.7%	$70.00 ➝ $62.00	Buy ➝ Buy
HPP Hudson Pacific Properties	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.98 -1.2%	$4.00 ➝ $5.00	Market Perform ➝ Outperform
HUN Huntsman	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Sison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.83 -2.3%	$22.00 ➝ $20.00	Overweight ➝ Overweight
HXL Hexcel	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Ciarmoli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$56.28 -3.1%	$85.00 ➝ $80.00	Buy ➝ Buy
IAS Integral Ad Science	Downgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Kesavabhotla Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.24 -4.6%		Strong-Buy ➝ Hold
IAS Integral Ad Science	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.24 -4.6%	$16.00 ➝ $9.00	Outperform ➝ Neutral
ICCM IceCure Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.11 +0.5%	$2.50 ➝ $2.50	Buy ➝ Buy
IKT Inhibikase Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.29 -3.4%		Neutral ➝ Neutral
IPHA Innate Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.96 -0.6%	$11.50 ➝ $11.50	Buy ➝ Buy
IPSC Century Therapeutics	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kelsey Goodwin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.51 -6.5%		Buy ➝ Buy
IPWR Ideal Power	Initiated by	Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.07 +0.4%		Hold
ITGR Integer	Initiated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the recommendation accuracy rating	$117.09 -0.3%	$145.00	Outperform
IVA Inventiva	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ed Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.93 -3.6%	$13.00 ➝ $13.00	Buy ➝ Buy
KEX Kirby	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.77 -2.1%	$133.00 ➝ $123.00	Buy ➝ Buy
KEY KeyCorp	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.80 -2.3%	$22.00 ➝ $20.00	Overweight ➝ Overweight
KLAC KLA	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$673.60 -3.8%	$875.00 ➝ $725.00	Buy ➝ Hold
KMB Kimberly-Clark	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$140.73 +0.1%	$130.00 ➝ $140.00	Equal Weight ➝ Equal Weight
KRC Kilroy Realty	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Caitlin Burrows Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.26 -2.8%	$42.00 ➝ $36.00	Buy ➝ Neutral
LCID Lucid Group	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.32 -4.1%	$3.00 ➝ $3.00	Neutral ➝ Neutral
LINC Lincoln Educational Services	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.71 -1.8%	$23.00	Buy
LINE Lineage	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Mailman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.98 -1.5%	$64.00	Neutral
LRCX Lam Research	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.61 -2.9%	$95.00 ➝ $100.00	Buy ➝ Buy
LSPD Lightspeed Commerce	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.08 -3.1%	$15.00 ➝ $13.00	Equal Weight ➝ Equal Weight
LSPD Lightspeed Commerce	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Bauch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.08 -3.1%	$13.00 ➝ $11.00	Equal Weight ➝ Equal Weight
LSPD Lightspeed Commerce	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.08 -3.1%	$17.00 ➝ $14.00	Equal Weight ➝ Equal Weight
30-year market phenomenon opens up overnight opportunity (Ad) Imagine this: When things worked out, you woke up, checked your account, and saw that you’ve made money overnight. Sounds like a dream, right? Well, what if that wasn’t a dream anymore? Earning while you sleep isn’t easy, and it definitely doesn’t happen overnight for most people. Tap here for the full breakdown.
LSPD Lightspeed Commerce	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.08 -3.1%	$15.00 ➝ $12.00	Hold
LULU Lululemon Athletica	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$293.06 -14.2%	$470.00 ➝ $420.00	Buy
LULU Lululemon Athletica	Target Set by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$293.06 -14.2%	$330.00	Negative
LULU Lululemon Athletica	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$460.00 ➝ $380.00	Buy ➝ Buy
LULU Lululemon Athletica	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$313.00 ➝ $302.00	Market Perform ➝ Market Perform
LULU Lululemon Athletica	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ashley Owens Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$420.00 ➝ $400.00	Overweight ➝ Overweight
LULU Lululemon Athletica	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$411.00 ➝ $309.00	Equal Weight ➝ Equal Weight
LULU Lululemon Athletica	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$375.00 ➝ $315.00	Equal Weight ➝ Equal Weight
LULU Lululemon Athletica	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$376.00 ➝ $335.00	Neutral ➝ Neutral
LULU Lululemon Athletica	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jim Duffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$438.00 ➝ $424.00	Buy ➝ Buy
LULU Lululemon Athletica	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$340.00 ➝ $315.00	Neutral ➝ Neutral
LULU Lululemon Athletica	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rick Patel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$430.00	Outperform ➝ Market Perform
LULU Lululemon Athletica	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexandra Steiger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$411.00 ➝ $373.00	Overweight ➝ Overweight
LULU Lululemon Athletica	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$480.00 ➝ $400.00	Buy ➝ Buy
LULU Lululemon Athletica	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$437.00 ➝ $391.00	Overweight ➝ Overweight
LULU Lululemon Athletica	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$293.06 -14.2%	$445.00 ➝ $385.00	Outperform ➝ Outperform
LUV Southwest Airlines	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Trent Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.58 -1.0%	$27.00 ➝ $30.00	Sell ➝ Sell
LVLU Lulu's Fashion Lounge	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.39 -8.3%	$2.00 ➝ $1.00	Market Perform ➝ Market Perform
LXRX Lexicon Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.57 +64.1%	$4.00 ➝ $4.00	Buy ➝ Buy
MIST Milestone Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Trucchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.88 -60.9%	$25.00 ➝ $25.00	Buy ➝ Buy
MMSI Merit Medical Systems	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.94 +0.6%	$120.00	Overweight
MRUS Merus	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.61 -0.5%	$109.00 ➝ $109.00	Buy ➝ Buy
MS Morgan Stanley	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$115.23 -3.2%	$142.00 ➝ $130.00	Equal Weight ➝ Equal Weight
MTB M&T Bank	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$175.21 -2.5%	$205.00 ➝ $185.00	Underweight ➝ Underweight
NCNO nCino	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Tomasello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.92 -1.9%	$44.00 ➝ $40.00	Outperform ➝ Outperform
NOAH Noah	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Li Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.09 -3.2%	$11.50	Neutral ➝ Neutral
NTRS Northern Trust	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$97.15 -3.4%	$119.00 ➝ $118.00	Equal Weight ➝ Equal Weight
NVT nVent Electric	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bradley Thomas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.89 -3.1%	$84.00 ➝ $75.00	Overweight ➝ Overweight
OCX OncoCyte	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Flaten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.21 -0.3%	$5.00	Buy
OLMA Olema Pharmaceuticals	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.11 -2.1%	$30.00 ➝ $28.00	Overweight ➝ Overweight
ONTO Onto Innovation	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$121.99 -5.0%	$245.00 ➝ $175.00	Buy ➝ Buy
ONTO Onto Innovation	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$121.99 -5.0%	$250.00 ➝ $200.00	Buy ➝ Buy
OS Onestream	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Hotchkiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.95 -5.5%	$36.00 ➝ $31.00	Buy ➝ Buy
OXM Oxford Industries	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ashley Owens Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.93 -5.8%		Overweight ➝ Sector Weight
OXM Oxford Industries	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mauricio Serna Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.93 -5.8%	$66.00 ➝ $57.00	Neutral ➝ Neutral
PNC The PNC Financial Services Group	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$171.83 -1.8%	$235.00 ➝ $230.00	Overweight ➝ Overweight
PTGX Protagonist Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Zhong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.88 -1.1%	$70.00 ➝ $70.00	Outperform ➝ Outperform
QTWO Q2	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Hotchkiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$80.71 -2.4%	$119.00 ➝ $106.00	Buy ➝ Buy
RACE Ferrari	Upgraded by	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Besson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$429.93 +0.7%		Hold ➝ Buy
RACE Ferrari	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	H. Cosman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$429.93 +0.7%		Equal Weight ➝ Overweight
RBLX Roblox	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$58.99 -0.9%	$65.00	Sector Perform
RDDT Reddit	Target Set by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$107.57 -2.4%	$155.00
RDDT Reddit	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.57 -2.4%		Outperform ➝ Outperform
RF Regions Financial	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.42 -2.3%	$28.00 ➝ $26.00	Equal Weight ➝ Equal Weight
RITM Rithm Capital	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay McCanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.39 -2.1%	$14.00 ➝ $14.00	Outperform ➝ Outperform
ROKU Roku	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.49 -4.7%	$93.00	Outperform
RPRX Royalty Pharma	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Verdult Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.37 -0.9%		Buy ➝ Buy
SEMR Semrush	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Merwin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.59 -2.7%	$14.00 ➝ $12.00	Neutral ➝ Neutral
SEPN Septerna	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Archila Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.10 -3.0%	$14.00 ➝ $11.00	Equal Weight ➝ Equal Weight
SGHC Super Group	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Clark Lampen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.63 -1.7%	$9.00	Buy
Trump’s Secret Weapon (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today
SKT Tanger	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Caitlin Burrows Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.88 +0.0%	$39.00 ➝ $40.00	Neutral ➝ Buy
SLNO Soleno Therapeutics	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Condulis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.99 +6.8%	$74.00 ➝ $108.00	Buy ➝ Buy
SLNO Soleno Therapeutics	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.99 +6.8%	$70.00 ➝ $81.00	Buy ➝ Buy
SMWB Similarweb	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Hotchkiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.39 -2.4%	$15.00 ➝ $13.00	Buy ➝ Buy
SNDR Schneider National	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.61 -3.7%	$34.00 ➝ $25.00	Buy ➝ Neutral
SNSE Sensei Biotherapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Edward White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.51 +18.0%	$4.00 ➝ $4.00	Buy ➝ Buy
SNSE Sensei Biotherapeutics	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Francois Brisebois Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.51 +18.0%	$3.50 ➝ $4.00	Outperform ➝ Outperform
SNX TD SYNNEX	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Cardoso Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$150.00 ➝ $125.00	Neutral ➝ Neutral
SNX TD SYNNEX	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$150.00 ➝ $138.00	Buy ➝ Buy
SNX TD SYNNEX	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$148.00 ➝ $125.00	Equal Weight ➝ Equal Weight
SNX TD SYNNEX	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vincent Colicchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$156.00 ➝ $156.00	Outperform ➝ Outperform
SNX TD SYNNEX	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Ng Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$154.00 ➝ $137.00	Buy ➝ Buy
SNX TD SYNNEX	Target Lowered by	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shreya Gheewala Subscribe to MarketBeat All Access for the recommendation accuracy rating	$104.45 -2.9%	$147.00 ➝ $132.00	Buy ➝ Buy
SOBO South Bow	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.18 +0.6%	$28.00	Neutral
SPOT Spotify Technology	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Cahall Subscribe to MarketBeat All Access for the recommendation accuracy rating	$559.76 -3.5%	$690.00 ➝ $740.00	Overweight ➝ Overweight
SPOT Spotify Technology	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$559.76 -3.5%	$645.00	Sector Perform
STT State Street	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$88.95 -3.1%	$118.00 ➝ $113.00	Overweight ➝ Overweight
SUN Sunoco	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.14 +0.9%	$62.00 ➝ $61.00	Overweight ➝ Overweight
SVRA Savara	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.91 +4.7%	$6.00 ➝ $6.00	Buy ➝ Buy
TFC Truist Financial	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.46 -2.3%	$52.00 ➝ $50.00	Overweight ➝ Overweight
TFII TFI International	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.00 -6.1%	$135.00 ➝ $128.00	Buy
TLN Talen Energy	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the recommendation accuracy rating	$197.48 -2.6%	$295.00 ➝ $265.00	Overweight ➝ Overweight
TLSI TriSalus Life Sciences	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Plovanic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.62 +2.2%	$11.00 ➝ $11.00	Buy ➝ Buy
TMC TMC the metals	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.72 +1.2%	$4.00 ➝ $4.00	Neutral ➝ Neutral
TPST Tempest Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.77 -8.1%	$47.00 ➝ $16.00	Buy ➝ Buy
TPST Tempest Therapeutics	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Farmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.77 -8.1%	$13.00 ➝ $7.00	Sector Outperform ➝ Sector Outperform
TSLA Tesla	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Edison Yu Subscribe to MarketBeat All Access for the recommendation accuracy rating	$263.55 -3.5%	$420.00 ➝ $345.00	Buy ➝ Buy
TTAM Titan America	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Brophy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.16 -1.1%	$19.00 ➝ $16.00	Buy ➝ Buy
TTAM Titan America	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Revich Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.16 -1.1%	$19.00 ➝ $16.50	Neutral ➝ Neutral
TXRH Texas Roadhouse	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nick Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$171.05 -2.1%	$200.00 ➝ $210.00	Outperform ➝ Outperform
TYRA Tyra Biosciences	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.77 +1.1%	$30.00	Outperform
UFPT UFP Technologies	Initiated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the recommendation accuracy rating	$199.32 -1.9%		Market Perform
USB U.S. Bancorp	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.21 -2.4%	$62.00 ➝ $56.00	Overweight ➝ Overweight
UTI Universal Technical Institute	Initiated by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.36 -4.3%	$31.00	Buy
VOYA Voya Financial	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Shanker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$67.32 -3.0%	$79.00 ➝ $71.00	Neutral ➝ Underperform
VRNS Varonis Systems	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.64 -0.1%	$50.00	Peer Perform ➝ Outperform
VRNT Verint Systems	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.85 -4.7%	$38.00 ➝ $30.00	Outperform ➝ Outperform
VST Vistra	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the recommendation accuracy rating	$119.05 -0.2%	$203.00 ➝ $186.00	Overweight ➝ Overweight
VTSI VirTra	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jaeson Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.27 -17.2%	$10.00 ➝ $7.00	Buy ➝ Buy
WGO Winnebago Industries	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Swartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.74 -7.5%	$58.00 ➝ $50.00	Buy ➝ Buy
WGO Winnebago Industries	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tristan Thomas-Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.74 -7.5%	$70.00 ➝ $60.00	Outperform ➝ Outperform
WK Workiva	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Hotchkiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$78.66 -3.0%	$132.00 ➝ $118.00	Buy ➝ Buy
WKSP Worksport	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.48 +3.9%	$1.50 ➝ $11.50	Buy ➝ Buy
WLK Westlake	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Osterland Subscribe to MarketBeat All Access for the recommendation accuracy rating	$99.09 -3.7%	$166.00 ➝ $155.00	Buy ➝ Buy
WMG Warner Music Group	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Thornton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.56 -2.2%	$35.00	Sector Perform
XOMA XOMA	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.33 -3.1%	$104.00 ➝ $104.00	Buy ➝ Buy
XPO XPO	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$107.36 -5.2%	$150.00 ➝ $131.00	Buy ➝ Buy
Z Zillow Group	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Tomasello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.74 -2.3%	$80.00	Market Perform
ZION Zions Bancorporation, National Association	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.47 -1.6%	$62.00 ➝ $58.00	Equal Weight ➝ Equal Weight
ZNTL Zentalis Pharmaceuticals	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Driscoll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.81 +1.1%	$4.00 ➝ $4.00	Neutral ➝ Neutral
Here’s how you could profit from Elon’s NVIDIA partnership (Ad) Elon Musk recently offered NVIDIA $1 billion... To buy a cluster of their cutting-edge GB200 AI chips. Why? Because Elon is quietly building the most powerful AI supercomputer on the planet. It's called "Project Colossus"... Don't know where to start investing in AI? Check out my latest investor briefing.

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:36 PM ET.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Price Targets and Analyst Ratings

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools